Assertio (ASRT) Stock Forecast, Price Target & Predictions
ASRT Stock Forecast
Assertio stock forecast is as follows: an average price target of $3.00 (represents a 233.37% upside from ASRT’s last price of $0.90) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
ASRT Price Target
The average price target for Assertio (ASRT) is $3.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $3.00. This represents a potential 233.37% upside from ASRT's last price of $0.90.
ASRT Analyst Ratings
According to 2 Wall Street analysts, Assertio's rating consensus is 'Buy'. The analyst rating breakdown for ASRT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Assertio Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | Naz Rahman | Maxim Group | $3.00 | $1.47 | 104.08% | 233.37% |
| May 28, 2024 | Scott Henry | Industrial Alliance Securities | $2.75 | $1.00 | 175.00% | 205.59% |
The latest Assertio stock forecast, released on Jul 26, 2024 by Naz Rahman from Maxim Group, set a price target of $3.00, which represents a 104.08% increase from the stock price at the time of the forecast ($1.47), and a 233.37% increase from ASRT last price ($0.90).
Assertio Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $2.88 |
| Last Closing Price | $0.90 | $0.90 | $0.90 |
| Upside/Downside | -100.00% | -100.00% | 220.04% |
In the current month, the average price target of Assertio stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Assertio's last price of $0.90. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 03, 2024 | H.C. Wainwright | Buy | Initialise | |
| May 28, 2024 | Alliance Global Partners | Buy | Initialise |
Assertio's last stock rating was published by H.C. Wainwright on Jul 03, 2024. The company Initialise its ASRT rating from "null" to "Buy".
Assertio Financial Forecast
Assertio Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $35.63M | $40.99M | $42.47M | $50.35M | $34.21M | $35.13M | $36.54M | $33.33M | $25.47M | $25.37M | $26.84M | $30.18M | $34.56M | $20.62M | $20.92M | $59.23M | $55.15M |
| Avg Forecast | $27.40M | $27.60M | $27.79M | $27.99M | $33.66M | $32.42M | $31.29M | $30.50M | $28.67M | $28.87M | $30.08M | $29.30M | $33.60M | $50.17M | $39.83M | $37.64M | $47.33M | $31.36M | $31.78M | $32.66M | $30.38M | $21.64M | $19.98M | $23.98M | $27.30M | $32.35M | $25.17M | $10.95M | $25.01M | $50.57M |
| High Forecast | $28.03M | $28.23M | $28.43M | $28.63M | $34.42M | $33.16M | $32.00M | $30.79M | $29.33M | $28.87M | $30.08M | $29.97M | $34.37M | $50.30M | $40.74M | $38.50M | $48.41M | $31.36M | $31.78M | $32.66M | $30.38M | $21.64M | $19.98M | $23.98M | $27.30M | $32.35M | $25.17M | $10.95M | $25.01M | $50.57M |
| Low Forecast | $26.55M | $26.74M | $26.93M | $27.12M | $32.61M | $31.42M | $30.32M | $30.22M | $27.79M | $28.87M | $30.08M | $28.39M | $32.56M | $50.05M | $38.60M | $36.47M | $45.86M | $31.36M | $31.78M | $32.66M | $30.38M | $21.64M | $19.98M | $23.98M | $27.30M | $32.35M | $25.17M | $10.95M | $25.01M | $50.57M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.71% | 1.03% | 1.13% | 1.06% | 1.09% | 1.11% | 1.12% | 1.10% | 1.18% | 1.27% | 1.12% | 1.11% | 1.07% | 0.82% | 1.91% | 2.37% | 1.09% |
Assertio's average Quarter revenue forecast for Dec 23 based on 1 analysts is $33.60M, with a low forecast of $32.56M, and a high forecast of $34.37M. ASRT's average Quarter revenue forecast represents a -5.69% decrease compared to the company's last Quarter revenue of $35.63M (Sep 23).
Assertio EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-228.27M | $19.80M | $21.10M | $29.90M | $18.38M | $19.96M | $22.45M | $14.86M | $13.69M | $-4.39M | $14.59M | $-25.85M | $-273.00K | $-37.12M | $60.02M | $-158.70M | $41.21M |
| Avg Forecast | $-2.65M | $-2.67M | $-2.68M | $-2.70M | $-3.25M | $-3.13M | $-3.02M | $-2.95M | $-2.77M | $-2.79M | $-2.91M | $26.23M | $-3.24M | $-4.85M | $-3.85M | $20.73M | $5.32M | $9.48M | $9.60M | $16.39M | $9.18M | $6.54M | $6.04M | $16.05M | $8.25M | $9.78M | $7.61M | $3.31M | $7.56M | $15.28M |
| High Forecast | $-2.56M | $-2.58M | $-2.60M | $-2.62M | $-3.15M | $-3.03M | $-2.93M | $-2.92M | $-2.68M | $-2.79M | $-2.91M | $31.47M | $-3.14M | $-4.83M | $-3.73M | $24.88M | $6.39M | $9.48M | $9.60M | $19.67M | $9.18M | $6.54M | $6.04M | $19.26M | $8.25M | $9.78M | $7.61M | $3.31M | $7.56M | $15.28M |
| Low Forecast | $-2.71M | $-2.73M | $-2.75M | $-2.76M | $-3.32M | $-3.20M | $-3.09M | $-2.97M | $-2.83M | $-2.79M | $-2.91M | $20.98M | $-3.32M | $-4.86M | $-3.93M | $16.59M | $4.26M | $9.48M | $9.60M | $13.11M | $9.18M | $6.54M | $6.04M | $12.84M | $8.25M | $9.78M | $7.61M | $3.31M | $7.56M | $15.28M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 47.11% | -5.15% | 1.02% | 5.62% | 1.94% | 2.08% | 1.37% | 1.62% | 2.09% | -0.73% | 0.91% | -3.13% | -0.03% | -4.88% | 18.14% | -21.00% | 2.70% |
1 analysts predict ASRT's average Quarter EBITDA for Sep 23 to be $-4.85M, with a high of $-4.83M and a low of $-4.86M. This is -124.47% lower than Assertio's previous annual EBITDA (Jun 23) of $19.80M.
Assertio Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-279.54M | $8.47M | $-3.48M | $88.55M | $4.17M | $7.83M | $9.06M | $4.61M | $3.74M | $-14.17M | $4.54M | $-24.35M | $-10.52M | $-34.50M | $41.23M | $-192.63M | $3.33M |
| Avg Forecast | $6.67M | $4.77M | $3.81M | $3.81M | $635.71K | $-476.76K | $-1.91M | $-2.22M | $-3.59M | $-4.39M | $-3.05M | $11.43M | $-1.91M | $9.06M | $17.70M | $9.03M | $-17.02M | $6.70M | $9.52M | $7.14M | $7.62M | $11.43M | $11.43M | $5.00M | $-13.33M | $-11.43M | $-32.38M | $120.60M | $53.33M | $92.70M |
| High Forecast | $6.87M | $4.91M | $3.93M | $3.93M | $654.58K | $-457.56K | $-1.83M | $-2.14M | $-3.15M | $-4.21M | $-2.93M | $13.71M | $-1.83M | $9.33M | $18.23M | $10.84M | $-13.62M | $6.70M | $9.52M | $8.57M | $7.62M | $11.43M | $11.43M | $6.00M | $-13.33M | $-11.43M | $-32.38M | $144.72M | $53.33M | $92.70M |
| Low Forecast | $6.41M | $4.58M | $3.66M | $3.66M | $610.11K | $-490.91K | $-1.96M | $-2.29M | $-4.03M | $-4.52M | $-3.14M | $9.14M | $-1.96M | $8.69M | $16.99M | $7.23M | $-20.43M | $6.70M | $9.52M | $5.71M | $7.62M | $11.43M | $11.43M | $4.00M | $-13.33M | $-11.43M | $-32.38M | $96.48M | $53.33M | $92.70M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -30.86% | 0.48% | -0.39% | -5.20% | 0.62% | 0.82% | 1.27% | 0.60% | 0.33% | -1.24% | 0.91% | 1.83% | 0.92% | 1.07% | 0.34% | -3.61% | 0.04% |
Assertio's average Quarter net income forecast for Sep 23 is $9.06M, with a range of $8.69M to $9.33M. ASRT's average Quarter net income forecast represents a 6.95% increase compared to the company's last Quarter net income of $8.47M (Jun 23).
Assertio SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $21.00M | $16.77M | $16.90M | $13.71M | $11.90M | $10.54M | $10.64M | $13.28M | $9.31M | $26.23M | $7.73M | $23.13M | $25.75M | $28.13M | $27.31M | $22.95M | $36.12M |
| Avg Forecast | $15.25M | $15.35M | $15.46M | $15.57M | $18.73M | $18.04M | $17.41M | $16.97M | $15.95M | $16.06M | $16.74M | $13.41M | $18.70M | $27.92M | $22.16M | $10.60M | $24.85M | $17.05M | $17.28M | $8.38M | $16.52M | $11.77M | $10.87M | $8.50M | $14.84M | $17.59M | $13.69M | $5.95M | $13.60M | $27.50M |
| High Forecast | $15.59M | $15.71M | $15.82M | $15.93M | $19.15M | $18.45M | $17.81M | $17.13M | $16.32M | $16.06M | $16.74M | $16.09M | $19.12M | $27.98M | $22.67M | $12.72M | $29.82M | $17.05M | $17.28M | $10.06M | $16.52M | $11.77M | $10.87M | $10.20M | $14.84M | $17.59M | $13.69M | $5.95M | $13.60M | $27.50M |
| Low Forecast | $14.77M | $14.88M | $14.98M | $15.09M | $18.15M | $17.48M | $16.87M | $16.81M | $15.46M | $16.06M | $16.74M | $10.73M | $18.12M | $27.85M | $21.48M | $8.48M | $19.88M | $17.05M | $17.28M | $6.71M | $16.52M | $11.77M | $10.87M | $6.80M | $14.84M | $17.59M | $13.69M | $5.95M | $13.60M | $27.50M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.75% | 0.76% | 1.59% | 0.55% | 0.70% | 0.61% | 1.27% | 0.80% | 0.79% | 2.41% | 0.91% | 1.56% | 1.46% | 2.06% | 4.59% | 1.69% | 1.31% |
Assertio's average Quarter SG&A projection for Dec 23 is $18.70M, based on 1 Wall Street analysts, with a range of $18.12M to $19.12M. The forecast indicates a -11.00% fall compared to ASRT last annual SG&A of $21.00M (Sep 23).
Assertio EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-3.42 | $0.15 | $-0.07 | $1.83 | $0.09 | $0.17 | $0.20 | $0.10 | $0.08 | $-0.32 | $0.12 | $-0.80 | $-0.36 | $-1.40 | $2.32 | $-10.60 | $0.20 |
| Avg Forecast | $0.07 | $0.05 | $0.04 | $0.04 | $0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.04 | $-0.05 | $-0.03 | $-0.01 | $-0.02 | $0.10 | $0.19 | $0.18 | $0.57 | $0.07 | $0.10 | $0.08 | $0.08 | $0.12 | $0.12 | $0.08 | $-0.14 | $-0.12 | $-0.34 | $-0.32 | $0.56 | $0.97 |
| High Forecast | $0.07 | $0.05 | $0.04 | $0.04 | $0.01 | $-0.00 | $-0.02 | $-0.02 | $-0.03 | $-0.04 | $-0.03 | $-0.01 | $-0.02 | $0.10 | $0.19 | $0.19 | $0.59 | $0.07 | $0.10 | $0.08 | $0.08 | $0.12 | $0.12 | $0.08 | $-0.14 | $-0.12 | $-0.34 | $-0.32 | $0.56 | $0.97 |
| Low Forecast | $0.07 | $0.05 | $0.04 | $0.04 | $0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.04 | $-0.05 | $-0.03 | $-0.01 | $-0.02 | $0.09 | $0.18 | $0.17 | $0.55 | $0.07 | $0.10 | $0.08 | $0.08 | $0.12 | $0.12 | $0.08 | $-0.14 | $-0.12 | $-0.34 | $-0.32 | $0.56 | $0.97 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | -36.00% | 0.81% | -0.38% | 3.20% | 1.28% | 1.70% | 2.50% | 1.25% | 0.67% | -2.67% | 1.50% | 5.71% | 3.00% | 4.12% | -7.25% | -18.93% | 0.21% |
According to 1 Wall Street analysts, Assertio's projected average Quarter EPS for Sep 23 is $0.10, with a low estimate of $0.09 and a high estimate of $0.10. This represents a -36.67% decrease compared to ASRT previous annual EPS of $0.15 (Jun 23).
Assertio Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics | $2.46 | $8.00 | 225.20% | Buy |
| ASRT | Assertio | $0.93 | $3.00 | 222.58% | Buy |
| IRWD | Ironwood Pharmaceuticals | $3.53 | $8.50 | 140.79% | Buy |
| EOLS | Evolus | $11.73 | $24.00 | 104.60% | Buy |
| AMPH | Amphastar Pharmaceuticals | $40.85 | $66.00 | 61.57% | Buy |
| AMRX | Amneal Pharmaceuticals | $8.07 | $11.50 | 42.50% | Buy |
| ANIP | ANI Pharmaceuticals | $55.83 | $79.00 | 41.50% | Buy |
| COLL | Collegium Pharmaceutical | $30.90 | $42.33 | 36.99% | Buy |
| ALVO | Alvotech | $12.11 | $16.00 | 32.12% | Hold |
| ALKS | Alkermes | $30.75 | $37.50 | 21.95% | Hold |
| PCRX | Pacira BioSciences | $19.83 | $23.75 | 19.77% | Hold |
| NBIX | Neurocrine Biosciences | $136.69 | $156.14 | 14.23% | Buy |
| ITCI | Intra-Cellular Therapies | $86.96 | $93.33 | 7.33% | Buy |
| CTLT | Catalent | $63.48 | $63.50 | 0.03% | Hold |
| LFCR | Lifecore Biomedical | $7.47 | $6.50 | -12.99% | Buy |